Shandong Xinhua Pharmaceutical Company Limited
Symbole: 000756.SZ
SHZ
16.15
CNYPrix du marché aujourd'hui
22.4147
Ratio P/E
2.9139
Ratio PEG
8.86B
Cap MRK
- 0.01%
Rendement DIV
Shandong Xinhua Pharmaceutical Company Limited (000756-SZ) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 3643.84 | 918.3 | 1158.7 | 744.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | -137.64 | 0 | -48.4 | -56.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 4745.26 | 1017.1 | 1035.4 | 937.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.inventory | 4427.67 | 1313 | 1212 | 1027.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 237.57 | 65.9 | 50.8 | 44.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 13054.34 | 3314.3 | 3457 | 2754 | ||||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 16128.64 | 4082.6 | 4000.5 | 3765.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1913.47 | 494.9 | 474.1 | 466.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1913.47 | 494.9 | 474.1 | 466.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 1176.32 | 275.3 | 287.5 | 316.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 153.72 | 91.6 | 16 | 15.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 393.23 | 95.6 | 30.1 | 14.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 19765.37 | 5040 | 4808.2 | 4578.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 32819.72 | 8354.3 | 8265.1 | 7332 | ||||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 3935.84 | 666.4 | 1090.1 | 1066.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 2671.86 | 1073.2 | 835.5 | 693.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 102.71 | 5 | 33.7 | 28.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 3207.47 | 799.4 | 548.4 | 350.5 | ||||||||||||||||||||||||||||||
Deferred Revenue Non Current | 411.66 | 100.7 | 118.4 | 132.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 490.44 | - | - | - | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 636.64 | 597.3 | 639.7 | 45.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 4086.23 | 971.9 | 756.7 | 1179 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 7.07 | 1.6 | 2.7 | 4.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 13681.05 | 3457.9 | 3915.2 | 3680.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 2706.46 | 674.7 | 669.6 | 627.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 9120.77 | 2305.4 | 1988.1 | 1709.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 4793.33 | 819.2 | 744.7 | 647.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1507.66 | 753.8 | 724.1 | 484.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 18128.21 | 4553.1 | 4126.5 | 3467.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 32819.72 | 8354.3 | 8265.1 | 7332 | ||||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 889.79 | 222.6 | 223.4 | 183.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 19018 | 4775.8 | 4349.9 | 3651.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 32819.72 | - | - | - | ||||||||||||||||||||||||||||||
Total Investments | 1038.68 | 275.3 | 239.2 | 260.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 5880.91 | 1874.2 | 1383.9 | 1043.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-debt | 2237.07 | 955.8 | 225.1 | 299.1 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 486.79 | 496.5 | 426.3 | 362.1 | ||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 5.33 | 520.3 | 484.8 | 434.3 | ||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 577.52 | 6 | 20 | 13.7 | ||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 80.43 | -1917.3 | 46.4 | 4 | ||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -491.34 | -876.8 | -265.4 | -539.6 | ||||||||||||||||||||||||||
cash-flows.row.account-receivables | -423.54 | -423.5 | -717.3 | -751.1 | ||||||||||||||||||||||||||
cash-flows.row.inventory | -120.86 | -120.9 | -200.1 | 76.2 | ||||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -332.4 | 632.1 | 121.6 | ||||||||||||||||||||||||||
cash-flows.row.other-working-capital | 53.07 | 0 | 20 | 13.7 | ||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | -144.29 | 2044.7 | 46.1 | -15.4 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 487.09 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -321.28 | -325.1 | -244.8 | -249.2 | ||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 11.27 | 11.9 | 45.3 | 19.8 | ||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -9.94 | 0 | -45.3 | -19.8 | ||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 3.07 | 8.2 | 7.9 | 9.1 | ||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 15.04 | -8.2 | 7.9 | 2.4 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -301.84 | -313.3 | -228.9 | -237.7 | ||||||||||||||||||||||||||
cash-flows.row.debt-repayment | -572.67 | -25.7 | -888.7 | -559.7 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.dividends-paid | -173.23 | -134.9 | -163 | -148.4 | ||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 758.03 | -35.5 | 921 | 568.4 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -122.9 | -196.1 | -130.7 | -139.7 | ||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 12.4 | 6.9 | 15.7 | -7.9 | ||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 88.83 | -240.4 | 414.4 | -126.2 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 3262.6 | 918.3 | 1010.8 | 596.4 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 3173.78 | 1158.7 | 596.4 | 722.6 | ||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 487.09 | 273.4 | 758.2 | 259.1 | ||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -321.28 | -325.1 | -244.8 | -249.2 | ||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 165.81 | -51.7 | 513.5 | 9.9 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 7922.31 | 8008.7 | 7503 | 6560.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 5715.98 | 5800.2 | 5465.7 | 4786.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 2206.33 | 2208.5 | 2037.3 | 1773.7 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
income-statement-row.row.research-development | 449.03 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 139.5 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 718.33 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | -26.24 | -63.4 | 333.4 | 244.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 1663.48 | 1696 | 1493.9 | 1274.7 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 7379.46 | 7496.3 | 6959.6 | 6061.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-income | 13.12 | 12.3 | 10.5 | 8.8 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 38.56 | 41.1 | 49.7 | 53.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 718.33 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -1.49 | 18.9 | -4.9 | -4.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -26.24 | -63.4 | 333.4 | 244.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -1.49 | 18.9 | -4.9 | -4.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 38.56 | 41.1 | 49.7 | 53.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 197.93 | 520.3 | 572.6 | 511.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 716.06 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-income | 518.13 | 512.4 | 476.7 | 425.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 516.64 | 531.3 | 471.8 | 421.2 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 19.18 | 26.6 | 45.5 | 59.2 | ||||||||||||||||||||||||||||||
income-statement-row.row.net-income | 486.79 | 496.5 | 411.1 | 348.5 |
Questions fréquemment posées
Quel est le total de Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) de l'actif total?
Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) Le total des actifs est 8354338037.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est 4064436167.000.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.278.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 0.245.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.061.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.065.
Qu'est-ce que Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 496512201.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 1874155569.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 1696039196.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 922054214.000.